Skip to main content
. 2019 Dec 8;55(1):28–36. doi: 10.1093/alcalc/agz089

Fig. 1.

Fig. 1

Prevalence of current and lifetime drinking measures (A) and noninvasive markers of liver disease (B) among NOAH study participants, stratified by HCV status.